Skip to content

Effects of Immunonutrition in Patients With Pneumonia

Effects of Immunonutrition on the Acute Immune Response in Hospitalized Patients With Pneumonia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04249050
Enrollment
40
Registered
2020-01-30
Start date
2020-03-30
Completion date
2020-08-15
Last updated
2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Infection, Malnutrition, Muscle Loss, Pneumonia, Pulmonary Disease

Brief summary

The project is a randomized controlled trial taking place in the North Zealand hospital in the city Hilleroed, Denmark. The aim is to investigate the potential beneficial effects of immunonutrition containing fish oil, arginine and RNA, on the acute immune response in patients with pneumonia.

Detailed description

Immunonutrition has a well-documented beneficial effect on surgical patients by strengthening the immune system and reducing the following: inflammation, the number of infections as well as hospitalization time. A study in operated patients demonstrated the benefit of immunonutrition by reducing unwanted inflammation, measured by the pro-inflammatory signalling protein, interleukin-6. The same study saw a smaller decrease in immune function (measured as the level of phagocytosis) in the group receiving immunonutrition than in the control group. This project will investigate whether similar effects can be detected in patients with pneumonia. The project is being carried out in a collaboration between the University of Copenhagen, The main hospital of Copenhagen (Rigshospitalet) and North Zealand Hospital. The project is a randomized clinical intervention study, which spans 10 days. Participants are allocated to the intervention group or the control group. The project is being carried out at the North Zealand hospital, at the Department of Pulmonary- and Infectious Diseases. The intervention group receives the department's standard treatment (Standard Of Care) + immunonutrition, while the control group receives the hospital department's standard treatment (Standard Of Care). On a daily basis, the patient's clinical condition and the activity of the immune system is measured for the purpose of determine whether there is an effect of immunonutrition.

Interventions

DIETARY_SUPPLEMENTOral Impact powder

Oral nutritional supplement containing fish oil, arginine and RNA

Sponsors

University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Authorized individuals diagnosed with pneumonia who speak and write in danish

Exclusion criteria

* individuals with Immunodeficiency * individuals with another primary diagnose * individuals with an allergy against product ingredients * individuals with dementia * individuals with dysphagia * individuals with cancer in treatment * individuals with Chronic Obstructive Pulmonary Disease on continuing steroid treatment or home administered oxygen treatment

Design outcomes

Primary

MeasureTime frameDescription
Interleukin-6daily measure from first day of inclusion until discharge (maximum 10 days)Measure of the acute immune response

Secondary

MeasureTime frameDescription
Length of stayFrom admittance to discharge (maximum 10 days)Measure of hospitalized days
Hand grip strengthDaily from admittance to discharge (maximum 10 days)Measure of the mobilization of strength

Countries

Denmark

Contacts

Primary ContactJens R Andersen, Assoc. Prof.
jra@nexs.ku.dk004523346654
Backup ContactAnna G Eilersen, student
hbj467@alumni.ku.dk004529246129

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026